Fast-acting insulin aspart

DRUG6 trials

Sponsors

Novo Nordisk A/S, Aristotle University Of Thessaloniki, Kirsten Nørgaard

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 1 DiabetesType 1 Diabetes

Phase 1

A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes Mellitus

CompletedNCT04655690

Novo Nordisk A/SDiabetes Mellitus, Type 1

Start: 2020-11-09End: 2021-11-26Updated: 2023-01-03

Phase 2

Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 Diabetes

CompletedNCT03816761

Novo Nordisk A/SDiabetes Mellitus, Type 1

Start: 2019-02-25End: 2019-06-10Updated: 2020-06-11

Phase 4

Fast-Acting Insulin Aspart and Insulin Pump Settings

Kirsten NørgaardType 1 Diabetes

Start: 2021-02-01End: 2022-06-30Target: 40Updated: 2021-02-16

Unknown Phase

Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients in Their Daily Lives, With the Help of the Freestyle Libre® Device

CompletedNCT03450863

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1 Diabetes

Start: 2018-03-22End: 2019-09-04Updated: 2020-03-18

Fiasp® Versus NovoRapid® in Children With Type 1 Diabetes on MiniMed 640G Pump With Sensor

CompletedNCT04149262

Aristotle University Of ThessalonikiType 1 Diabetes

Start: 2019-11-15End: 2023-02-15Updated: 2026-03-11

A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice

CompletedNCT05069545

Novo Nordisk A/SDiabetes Mellitus, Type 1

Start: 2021-10-11End: 2024-09-10Updated: 2025-12-31

Related Papers

Improvements in Glycemic Control Achieved by Altering the t<sub>max</sub> Setting in the iLet<sup>®</sup> Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial.

2021-06-1911 citations

Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study

Diabetes Technology & Therapeutics2020-09-1431 citations

1043-P: GoBolus Study: Impact of Faster Aspart on Glycemic Control in a Real-World Population with Type 1 Diabetes on Basal-Bolus Therapy as Multiple Daily Injections Using Flash Glucose Monitoring

Diabetes2020-06-01